Rodrigo Alonso

Summary

Country: Spain

Publications

  1. ncbi request reprint Lipoprotein(a) levels in familial hypercholesterolemia: an important predictor of cardiovascular disease independent of the type of LDL receptor mutation
    Rodrigo Alonso
    Department of Internal Medicine, IIS Fundación Jiménez Díaz, Madrid, Spain Electronic address
    J Am Coll Cardiol 63:1982-9. 2014
  2. doi request reprint Early diagnosis and treatment of familial hypercholesterolemia: improving patient outcomes
    Rodrigo Alonso
    Lipid Clinic, Internal Medicine Department, IIS Fundación Jiménez Díaz, Madrid, Spain
    Expert Rev Cardiovasc Ther 11:327-42. 2013
  3. doi request reprint Cardiovascular disease in familial hypercholesterolaemia: influence of low-density lipoprotein receptor mutation type and classic risk factors
    R Alonso
    Lipid Clinic, Fundacion Jimenez Diaz, Madrid, Spain
    Atherosclerosis 200:315-21. 2008
  4. pmc R353Q polymorphism in the factor VII gene and cardiovascular risk in Heterozygous Familial Hypercholesterolemia: a case-control study
    Juan Criado-García
    Lipids and Atherosclerosis Unit, Department of Medicine, IMIBIC Hospital Universitario Reina Sofía Universidad de Córdoba, Spain
    Lipids Health Dis 10:50. 2011
  5. pmc Clinical characteristics and evaluation of LDL-cholesterol treatment of the Spanish Familial Hypercholesterolemia Longitudinal Cohort Study (SAFEHEART)
    Nelva Mata
    Department of Epidemiology, Madrid Health Authority and Fundación Hipercolesterolemia Familiar, Madrid, Spain
    Lipids Health Dis 10:94. 2011
  6. ncbi request reprint Benefits and risks assessment of simvastatin in familial hypercholesterolaemia
    Rodrigo Alonso
    Fundacion Jimenez Diaz, Lipid Clinic, Internal Medicine Department, Madrid 28040, Spain
    Expert Opin Drug Saf 4:171-81. 2005
  7. doi request reprint Detection of subclinical atherosclerosis in familial hypercholesterolemia using non-invasive imaging modalities
    Paloma Caballero
    Department of Radiology, Hospital de la Princesa, Madrid, Spain
    Atherosclerosis 222:468-72. 2012
  8. doi request reprint Genetic diagnosis of familial hypercholesterolemia using a DNA-array based platform
    Rodrigo Alonso
    Lipid Clinic, Fundacion Jimenez Diaz, Madrid, Spain
    Clin Biochem 42:899-903. 2009
  9. doi request reprint Cost-effectiveness of managing familial hypercholesterolemia using atorvastatin-based preventive therapy
    Rodrigo Alonso
    Unidad de Lipidos, Fundacion Jimenez Diaz, Madrid, Spain
    Rev Esp Cardiol (Engl Ed) 61:382-93. 2008
  10. ncbi request reprint MEDPED and the Spanish Familial Hypercholesterolemia Foundation
    Pedro Mata
    Unidad de Lipidos, Fundacion Jimenez Diaz, Madrid, Spain
    Atheroscler Suppl 2:9-11. 2002

Collaborators

Detail Information

Publications13

  1. ncbi request reprint Lipoprotein(a) levels in familial hypercholesterolemia: an important predictor of cardiovascular disease independent of the type of LDL receptor mutation
    Rodrigo Alonso
    Department of Internal Medicine, IIS Fundación Jiménez Díaz, Madrid, Spain Electronic address
    J Am Coll Cardiol 63:1982-9. 2014
    ..The aim of this study was to determine the relationship between lipoprotein(a) [Lp(a)] and cardiovascular disease (CVD) in a large cohort of patients with heterozygous familial hypercholesterolemia (FH)...
  2. doi request reprint Early diagnosis and treatment of familial hypercholesterolemia: improving patient outcomes
    Rodrigo Alonso
    Lipid Clinic, Internal Medicine Department, IIS Fundación Jiménez Díaz, Madrid, Spain
    Expert Rev Cardiovasc Ther 11:327-42. 2013
    ....
  3. doi request reprint Cardiovascular disease in familial hypercholesterolaemia: influence of low-density lipoprotein receptor mutation type and classic risk factors
    R Alonso
    Lipid Clinic, Fundacion Jimenez Diaz, Madrid, Spain
    Atherosclerosis 200:315-21. 2008
    ....
  4. pmc R353Q polymorphism in the factor VII gene and cardiovascular risk in Heterozygous Familial Hypercholesterolemia: a case-control study
    Juan Criado-García
    Lipids and Atherosclerosis Unit, Department of Medicine, IMIBIC Hospital Universitario Reina Sofía Universidad de Córdoba, Spain
    Lipids Health Dis 10:50. 2011
    ..To date, no study has evaluated the association between factor VII and coronary artery disease in patients with FH...
  5. pmc Clinical characteristics and evaluation of LDL-cholesterol treatment of the Spanish Familial Hypercholesterolemia Longitudinal Cohort Study (SAFEHEART)
    Nelva Mata
    Department of Epidemiology, Madrid Health Authority and Fundación Hipercolesterolemia Familiar, Madrid, Spain
    Lipids Health Dis 10:94. 2011
    ..Despite the use of statins, most patients do not achieve an optimal LDL-cholesterol goal. The aims of this study are to describe baseline characteristics and to evaluate Lipid Lowering Therapy (LLT) in FH patients recruited in SAFEHEART...
  6. ncbi request reprint Benefits and risks assessment of simvastatin in familial hypercholesterolaemia
    Rodrigo Alonso
    Fundacion Jimenez Diaz, Lipid Clinic, Internal Medicine Department, Madrid 28040, Spain
    Expert Opin Drug Saf 4:171-81. 2005
    ..The efficacy and tolerability of simvastatin at doses up to 80 mg/day are well-established, as well as its cost-effectiveness in the management of FH patients...
  7. doi request reprint Detection of subclinical atherosclerosis in familial hypercholesterolemia using non-invasive imaging modalities
    Paloma Caballero
    Department of Radiology, Hospital de la Princesa, Madrid, Spain
    Atherosclerosis 222:468-72. 2012
    ..To investigate the extent of subclinical atherosclerosis in asymptomatic familial hypercholesterolemia (FH) patients using non-invasive images techniques...
  8. doi request reprint Genetic diagnosis of familial hypercholesterolemia using a DNA-array based platform
    Rodrigo Alonso
    Lipid Clinic, Fundacion Jimenez Diaz, Madrid, Spain
    Clin Biochem 42:899-903. 2009
    ..This platform includes the use of a DNA micro array, the detection of large gene rearrangements and the complete resequencing of the low-density lipoprotein receptor gene...
  9. doi request reprint Cost-effectiveness of managing familial hypercholesterolemia using atorvastatin-based preventive therapy
    Rodrigo Alonso
    Unidad de Lipidos, Fundacion Jimenez Diaz, Madrid, Spain
    Rev Esp Cardiol (Engl Ed) 61:382-93. 2008
    ....
  10. ncbi request reprint MEDPED and the Spanish Familial Hypercholesterolemia Foundation
    Pedro Mata
    Unidad de Lipidos, Fundacion Jimenez Diaz, Madrid, Spain
    Atheroscler Suppl 2:9-11. 2002
    ..Analysis of LDL-receptor gene have been performed in 350 cases and 86 different mutations have been found...
  11. ncbi request reprint [Cost-effectiveness of managing familial hypercholesterolemia using atorvastatin-based preventive therapy]
    Rodrigo Alonso
    Unidad de Lipidos, Fundacion Jimenez Diaz, Madrid, Espana
    Rev Esp Cardiol 61:382-93. 2008
    ....
  12. ncbi request reprint Benefits and risks of simvastatin in patients with familial hypercholesterolaemia
    Pedro Mata
    Lipid Clinic, Internal Medicine Department, Fundacion Jimenez Diaz, Madrid, Spain
    Drug Saf 26:769-86. 2003
    ..Early intervention with simvastatin treatment can be successfully implemented with favourable economic benefits...
  13. doi request reprint Omega-3 fatty acids and blood pressure
    Jorge Cabo
    Internal Medicine Department, Hospital Universitario Santa Cristina, Madrid, Spain
    Br J Nutr 107:S195-200. 2012
    ..3 polyunsaturated fatty acids consumption might have a place in the control of patients with mild hypertension before starting drug treatment and of those who prefer changes of lifestyles like diet...